Results showed that GPX3 methylation was detected in 77.1% (162/210) of RCC tumors, but only 14.6% (7/48) in adjacent non-malignant renal tissues, suggesting tumor-specific methylation of GPX3 in RCC. Here, GPX3 is linked to renal cell carcinoma.